Trial intelligence / Profile preview

Entecavir vs placebo in pediatric HBeAg‑positive chronic hepatitis B

2009-016357-17Phase 3Completed

Sponsor
Bristol Myers Squibb
Start
Oct 2010
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of entecavir in Chronic Hepatitis B (CHB), sponsored by Bristol Myers Squibb. Started Oct 2010; status: completed.

02

Drugs

entecavir
03

Conditions

Chronic Hepatitis B (CHB)

Beyond the preview

Go deeper on 2009-016357-17.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2009-016357-17.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call